U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H24N2O4
Molecular Weight 308.3728
Optical Activity ( - )
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of UBENIMEX

SMILES

CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O

InChI

InChIKey=VGGGPCQERPFHOB-RDBSUJKOSA-N
InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1

HIDE SMILES / InChI
Ubenimex is a dipeptide, which specifically inhibits the activity of leukotriene A4 hydrolase, aminopeptidase B and leucine aminopeptidase of the cell membrane. The drug was isolated from Streptomyces oliooreticuli in 1976 in Nippon Kayaku, Japan and approved for the treatment of acute non-lymphocytic leukemia under the name Bestatin. In the USA the drug is currentlu in Phase II for the treatment of pulmonary arterial hypertension and lymphedema.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P09960
Gene ID: 4048.0
Gene Symbol: LTA4H
Target Organism: Homo sapiens (Human)
10.4 µM [IC50]
Target ID: P28838
Gene ID: 51056.0
Gene Symbol: LAP3
Target Organism: Homo sapiens (Human)
Target ID: Q9H4A4
Gene ID: 6051.0
Gene Symbol: RNPEP
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
BESTATIN

Approved Use

Adjunct to chemotherapy agent to extend survival and to maintain remission after treatment for acute non-lymphocytic leukemia in adults.

Launch Date

1987
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation.
1996 Dec
Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.
1997 Dec
In vitro and in vivo evaluation of aminopeptidase inhibitors as antimicrosporidial therapies.
2001
Adult T-cell leukemia associated with gastric carcinoma: report of a case.
2001
[Effects of ubenimex ( bestatin) on the immunity of patients with squamous cell lung carcinoma treated with chemotherapy].
2001 Oct 20
Possible involvement of placental peptidases that degrade gonadotropin-releasing hormone (GnRH) in the dynamic pattern of placental hCG secretion via GnRH degradation.
2002 Jul
Induction of graft-versus-host disease and a graft-versus-leukemia effect using ubenimex in a patient with infantile leukemia relapsing after an unrelated cord blood transplant.
2002 Oct
[Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients--effects, complications and long-term survival].
2003 Aug
Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways.
2003 Nov
[A case of renal cell carcinoma with lymph node metastasis keeping remission for five years by adjuvant immunotherapy with ubenimex].
2003 Oct
Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia.
2004 Aug
[Experimental study of the enhancement effect of aminopeptidase N inhibitor ubenimex on the differentiation induction activity of all-trans-retinoic acid in acute promyelocytic leukemia cells and its mechanism].
2006 Jul
CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells.
2006 Jun 5
Complete remission induced by gemtuzumab ozogamicin in a Jehovah's Witness patient with acute myelogenous leukemia.
2007 Jun
Characterization of the catalytically active Mn(II)-loaded argE-encoded N-acetyl-L-ornithine deacetylase from Escherichia coli.
2007 Jun
Aminopeptidase B, a glucagon-processing enzyme: site directed mutagenesis of the Zn2+-binding motif and molecular modelling.
2007 Oct 31
Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
2008 Mar 19
Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer.
2009 Nov
Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.
2010 Jan
Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase.
2011 Mar 24
The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria.
2012 Jun
Patents

Sample Use Guides

Administer 30 mg ubenimex orally once a day.
Route of Administration: Oral
In Vitro Use Guide
MT-1, MOLT-4, HL-60, K562 and Raji cells were cultured in the presence of ubenimex (4.5, 45, 450 ug/ml and 4.5 mg/ml) at 37C. The number of viable HL-60 cells decreased with time at a high concentration of the drug (4.5 mg/ml) with time. The number of viable MT-1 cells was also decreased at the concentrations 4.5 mg/ml and 450 ug/ml. The number of viable MOLT-4 cells did not decrease even at high concentrations. The number of viable Raji cells also decreased at 4.5 mg/ml, but was not affected at 450 ug/ml.
Name Type Language
UBENIMEX
INN   JAN   MART.   MI   WHO-DD  
INN  
Official Name English
UBENIMEX [MART.]
Common Name English
ubenimex [INN]
Common Name English
(-)-BESTATIN
Common Name English
BESTATIN
Common Name English
NSC-265489
Code English
NK-421
Code English
L-LEUCINE, N-((2S,3R)-3-AMINO-2-HYDROXY-1-OXO-4-PHENYLBUTYL)-
Systematic Name English
N-((2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTANOYL)-LEUCINE
Systematic Name English
Ubenimex [WHO-DD]
Common Name English
UBENIMEX [JAN]
Common Name English
UBENIMEX [MI]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/16/1638
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
FDA ORPHAN DRUG 749020
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
FDA ORPHAN DRUG 806720
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
FDA ORPHAN DRUG 755720
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
FDA ORPHAN DRUG 498115
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
NCI_THESAURUS C2139
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
Code System Code Type Description
FDA UNII
I0J33N5627
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
SMS_ID
100000076638
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
DRUG CENTRAL
2787
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
NSC
265489
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
NCI_THESAURUS
C1015
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
MESH
C012211
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
INN
5940
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
ECHA (EC/EINECS)
261-529-2
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
WIKIPEDIA
Ubenimex
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
CAS
58970-76-6
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
EVMPD
SUB11372MIG
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
DRUG BANK
DB03424
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
ChEMBL
CHEMBL29292
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
MERCK INDEX
m11294
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY Merck Index
PUBCHEM
72172
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY
EPA CompTox
DTXSID4048430
Created by admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
PRIMARY